#United States #St. Paul #cochlear implant #iotaSOFT #Robotic Assistance

iotaMotion's Revolutionary Leap in Cochlear Implant Technology

iotaMotion, Inc., renowned for its pioneering work in robotic-assisted systems for cochlear implant surgery, has recently announced a groundbreaking development in the field of auditory restoration. The company has successfully implemented its state-of-the-art iotaSOFT® Insertion System outside the United States for the first time, as part of an innovative clinical investigation at University Hospital of Zurich, Switzerland. This significant milestone not only underscores iotaMotion's commitment to advancing medical technology but could also change the landscape of cochlear implant procedures worldwide.

Utilizing Cutting-Edge Technology

The clinical study, titled "Analysis of electrocochleographic signals during speed-controlled cochlear implant electrode array insertion in a non-randomized controlled trial," is under the guidance of Professor Alexander Huber. With the clinical investigation in full swing, the iotaSOFT Insertion System is set to transform how cochlear implant surgeries are performed. This sophisticated technology has previously been utilized in more than 750 procedures across the U.S., marking it as a breakthrough in maximizing the efficiency and precision of electrode array insertions.

Professor Huber emphasized the importance of introducing this novel robotic-assisted technology, stating, "Bringing this new robotic-assisted technology for cochlear implantation to University of Zurich was extremely important to our team. It will enable us to continue to advance cochlear implant care and explore techniques that have never been used clinically prior to this study."

Advancing Cochlear Implant Procedures

The heart of this innovative technology lies in its ability to provide unparalleled control over the insertion process. Utilizing real-time electrocochleography (ECochG), the iotaSOFT system helps optimize intracochlear recordings, which could lead to advancements not only in how cochlear implants are programmed but also in preserving hearing in patients. This controlled approach contributes significantly to understanding cochlear function and the dynamics of electrode insertion, which is vital for achieving optimal hearing outcomes.

Mike Lobinsky, the President and CEO of iotaMotion, described this momentous occasion as a giant step forward. "This represents a major milestone for iotaMotion as we expand outside of the United States with our technology. The team in Zurich has been an exceptional partner, and we look forward to continuing our relationship."

While currently undergoing pre-market clinical investigation in Zurich, the future availability of the iotaSOFT Insertion System is anticipated in 2026, marking a new chapter for patients seeking cochlear implants.

About iotaMotion

Founded in St. Paul, Minnesota, iotaMotion, Inc. stands at the intersection of advanced medical technology and patient care. By developing robotic-assisted solutions that enhance the capabilities of surgical teams, the company seeks to redefine standards of care in cochlear implant surgery. Its flagship product, the iotaSOFT Insertion System, is already commercially viable in the U.S. market and shows great promise for future success in international markets.

For more details on their cutting-edge technology, visit iotaMotion's official website or reach out to Wade Colburn, Vice President of Marketing and Clinical, at [email protected].

This pioneering effort is set to pave the way for increased collaboration and innovation in cochlear implant technology, providing hope and improved quality of life for individuals with hearing impairments.